Jump to content

FGF10

From Wikipedia, the free encyclopedia
(Redirected from FGF-10)

FGF10
Available structures
PDBOrtholog search: PDBe RCSB
Identifiers
AliasesFGF10, fibroblast growth factor 10
External IDsOMIM: 602115; MGI: 1099809; HomoloGene: 3284; GeneCards: FGF10; OMA:FGF10 - orthologs
Orthologs
SpeciesHumanMouse
Entrez
Ensembl
UniProt
RefSeq (mRNA)

NM_004465

NM_008002

RefSeq (protein)

NP_004456

NP_032028

Location (UCSC)Chr 5: 44.3 – 44.39 MbChr 13: 118.81 – 118.93 Mb
PubMed search[3][4]
Wikidata
View/Edit HumanView/Edit Mouse

Fibroblast growth factor 10 is a protein that in humans is encoded by the FGF10 gene.[5][6]

Function

[edit]

The protein encoded by this gene is a member of the fibroblast growth factor (FGF) family. FGF family members possess broad mitogenic and cell survival activities, and are involved in a variety of biological processes, including embryonic development, cell growth, morphogenesis, tissue repair, tumor growth and invasion. Fibroblast growth factor 10 is a paracrine signaling molecule seen first in the limb bud and organogenesis development. FGF10 starts the developing of limbs and its involved in the branching of morphogenesis in multiple organs such as the lungs, skin, ear and salivary glands. During the limb development Tbx4/Tbx5 stimulate the production of FGF10 in the lateral plate mesoderm where it will create an epithelial-mesenchymal FGF signal with FGF8. This positive feedback loop will increase the amount of mesenchyme resulting in a bulge. Afterwards, FGF10 will induce the formation of apical ectodermal ridge (AER) where the foot and hands will be formed. Lung development uses the same epithelial-mesenchymal signaling from FGF10 in the foregut mesenchyme with FGFR2 in the foregut epithelium. FGF10 signaling is required for epithelial branching. Therefore, all branching morphogen organs such as the lungs, skin, ear and salivary glands required the constant expression of FGF10. This protein exhibits mitogenic activity for keratinizing epidermal cells, but essentially no activity for fibroblasts, which is similar to the biological activity of FGF7.[6]

Clinical significance

[edit]

Nonsense mutations may also occur with the absence of FGF10 such as LADD and ALSG syndrome. Nevertheless, complications may arise from FGF10 signaling such as pancreatic and breast cancer. Moreover, studies have identified variants near the FGF10 locus as a genetic risk factor for breast cancer susceptibility.[7] Although this gene is also implicated to be a primary factor in the process of wound healing.[6] Heterozygous FGF10 variants and childhood intestinal lung disease (child) linked to potential early lethal outcomes. Also, FGF10 variants have been associated with abnormal epithelial repair.[8] FGF10 haploinsufficiency have been shown to increased risk of chronic‐obstructive pulmonary disease (COPD). Individuals with haploinsufficiency for FGF10 have significantly reduced Tiffeneau index, resembling chronic restrictive and obstructive pulmonary disease. [9]

Animal studies

[edit]

FGF10 knockout mice die right after birth. The mice showed no developing organs such as lungs, salivary glands, kidney or definitive limbs once autopsied. Studies of the mouse homolog suggested that this gene is required for embryonic epidermal morphogenesis including brain development, lung morphogenesis, and initiation of limb bud formation.[10] FGF Knockout mice also have impaired epicardial cell expansion following neonatal heart injury, as well as reduced expression of epicardial markers Wt1 and Tbx18, and mesenchymal markers such as Snai1, Twist1, and Postn.[11] Mice deficient for FGF10 fail to develop normal mammary glands. [12] Guinea Pig model has shown that FGF10 monoclonal antibody can decrease the number of inflammatory cells in the dermis and its inhibitory effect on inflammatory cells is like that of hydrocortisone butyrate. [13]

Interactions

[edit]

FGF10 has been shown to interact with Heparan sulfate [14] and Toll-like receptors. [15]

See also

[edit]

References

[edit]
  1. ^ a b c GRCh38: Ensembl release 89: ENSG00000070193Ensembl, May 2017
  2. ^ a b c GRCm38: Ensembl release 89: ENSMUSG00000021732Ensembl, May 2017
  3. ^ "Human PubMed Reference:". National Center for Biotechnology Information, U.S. National Library of Medicine.
  4. ^ "Mouse PubMed Reference:". National Center for Biotechnology Information, U.S. National Library of Medicine.
  5. ^ Emoto H, Tagashira S, Mattei MG, Yamasaki M, Hashimoto G, Katsumata T, et al. (September 1997). "Structure and expression of human fibroblast growth factor-10". The Journal of Biological Chemistry. 272 (37): 23191–23194. doi:10.1074/jbc.272.37.23191. PMID 9287324.
  6. ^ a b c "Entrez Gene: FGF10 fibroblast growth factor 10".
  7. ^ Rivetti S, Chen C, Chen C, Bellusci S (2020-06-26). "Fgf10/Fgfr2b Signaling in Mammary Gland Development, Homeostasis, and Cancer". Frontiers in Cell and Developmental Biology. 8: 415. doi:10.3389/fcell.2020.00415. PMC 7333592. PMID 32676501.
  8. ^ Schütz K, Schmidt A, Schwerk N, Renz DM, Gerard B, Schaefer E, et al. (November 2023). "Variants in FGF10 cause early onset of severe childhood interstitial lung disease: A detailed description of four affected children". Pediatric Pulmonology. 58 (11): 3095–3105. doi:10.1002/ppul.26627. PMID 37560881.
  9. ^ Klar J, Blomstrand P, Brunmark C, Badhai J, Håkansson HF, Brange CS, et al. (October 2011). "Fibroblast growth factor 10 haploinsufficiency causes chronic obstructive pulmonary disease". Journal of Medical Genetics. 48 (10): 705–709. doi:10.1136/jmedgenet-2011-100166. PMID 21742743.
  10. ^ Itoh N, Ohta H (May 2014). "Fgf10: a paracrine-signaling molecule in development, disease, and regenerative medicine". Current Molecular Medicine. 14 (4): 504–509. doi:10.2174/1566524014666140414204829. PMID 24730525.
  11. ^ Clayton NS, Grose RP (2018-10-24). "Emerging Roles of Fibroblast Growth Factor 10 in Cancer". Frontiers in Genetics. 9: 499. doi:10.3389/fgene.2018.00499. PMC 6207577. PMID 30405704.
  12. ^ Mailleux AA, Spencer-Dene B, Dillon C, Ndiaye D, Savona-Baron C, Itoh N, et al. (January 2002). "Role of FGF10/FGFR2b signaling during mammary gland development in the mouse embryo". Development. 129 (1): 53–60. doi:10.1242/dev.129.1.53. PMID 11782400.
  13. ^ Xia JX, Mei XL, Zhu WJ, Li X, Jin XH, Mou Y, et al. (2014). "Effect of FGF10 monoclonal antibody on psoriasis-like model in guinea pigs". International Journal of Clinical and Experimental Pathology. 7 (5): 2219–2228. PMC 4069920. PMID 24966930.
  14. ^ Izvolsky KI, Shoykhet D, Yang Y, Yu Q, Nugent MA, Cardoso WV (June 2003). "Heparan sulfate-FGF10 interactions during lung morphogenesis". Developmental Biology. 258 (1): 185–200. doi:10.1016/S0012-1606(03)00114-3. PMID 12781692.
  15. ^ Liu L, Song C, Li J, Wang Q, Zhu M, Hu Y, et al. (January 2020). "Fibroblast growth factor 10 alleviates particulate matter-induced lung injury by inhibiting the HMGB1-TLR4 pathway". Aging. 12 (2): 1186–1200. doi:10.18632/aging.102676. PMC 7053597. PMID 31958320.

Further reading

[edit]
[edit]